Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP399915.RAvfk-ZoViYQk3-HEwwfJBohjJBHdw0rRW7gFeD3PienI130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP399915.RAvfk-ZoViYQk3-HEwwfJBohjJBHdw0rRW7gFeD3PienI130_provenance.
• NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699366.RAgczxtEGcdsKD4pFtuTOiZtx3OI3AOaTYeogRN2T4i50130_provenance.
• NP470306.RA4iMFTnOnck8ffglQg-fK2lyFN4h-qkpYeD64DwAAuOs130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470306.RA4iMFTnOnck8ffglQg-fK2lyFN4h-qkpYeD64DwAAuOs130_provenance.
• NP869304.RAdfjbbJnNBdtvQqBj57BJM1CmnpaIGZ3u8lKLLSSmPkw130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869304.RAdfjbbJnNBdtvQqBj57BJM1CmnpaIGZ3u8lKLLSSmPkw130_provenance.
• NP432837.RAEobdLkuGrFe-ynKyhh1gybRAMNUmqfWCym8P6Vw5HoA130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432837.RAEobdLkuGrFe-ynKyhh1gybRAMNUmqfWCym8P6Vw5HoA130_provenance.
• NP978684.RAd89C7-sWmY4enSWlb6Qezi2viwueIQ3cOWmL3YatQqY130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978684.RAd89C7-sWmY4enSWlb6Qezi2viwueIQ3cOWmL3YatQqY130_provenance.
• assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781594.RAD_4bRFr-Btb8bdCAa0dlo41x5vMSeElH2ryFlKYL8js130_provenance.
• NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671061.RAaQ0VJf7inCNG-YP0o7afEw467MO9qxH24ZsafOLIqIA130_provenance.
• assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP914213.RAB95u8q3R9za0FFO4shvR-3p8o0LUZnarm4PrsqwhayY130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914213.RAB95u8q3R9za0FFO4shvR-3p8o0LUZnarm4PrsqwhayY130_provenance.
• NP671059.RAnGRaKfE75D2tsl7J3PI308CUlZxivjm6KJfcoMKwjqU130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671059.RAnGRaKfE75D2tsl7J3PI308CUlZxivjm6KJfcoMKwjqU130_provenance.
• NP671071.RAjWVjmEf0jEsKxxq6uOSCcn76DxH9Aak94MD5Lkl0sBQ130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671071.RAjWVjmEf0jEsKxxq6uOSCcn76DxH9Aak94MD5Lkl0sBQ130_provenance.
• NP606164.RAJQCtg09h8Y_IaXQmp2UgxyHFVofK-NsB-9PSeJdrK_k130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606164.RAJQCtg09h8Y_IaXQmp2UgxyHFVofK-NsB-9PSeJdrK_k130_provenance.
• NP873326.RAOls08eZKsPJLng_4asYPcsC8W_-4xK7MdNzls_Sf7pc130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873326.RAOls08eZKsPJLng_4asYPcsC8W_-4xK7MdNzls_Sf7pc130_provenance.
• NP671067.RA-WxRWOe5XCldQ12OKyz75mU-Yg9u2-dZtLpeccEmjRc130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671067.RA-WxRWOe5XCldQ12OKyz75mU-Yg9u2-dZtLpeccEmjRc130_provenance.
• NP671074.RAxAez1eb_d5VZvmiJaYvIZHrwnvYYJIf5m3YZbJV2wao130_assertion description "[The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic/myeloproliferative diseases (MDS/MPDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671074.RAxAez1eb_d5VZvmiJaYvIZHrwnvYYJIf5m3YZbJV2wao130_provenance.